Trial intelligence / Profile preview

Sedation vs General Anesthesia in Therapeutic Bronchoscopy

NCT03406546Terminated

Sponsor
Changhai Hospital
Start
Feb 2018
Primary completion
Jun 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, open-label trial of dexmedetomidine and remifentanil (2 arms), sponsored by Changhai Hospital. Primary endpoint: Recovery time at 3 hours. Started Feb 2018; status: terminated.

02

Drugs

dexmedetomidineremifentanil

Beyond the preview

Go deeper on NCT03406546.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03406546.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call